Abrdn PLC Horizon Therapeutics Public LTD CO Transaction History

Abrdn PLC

  • $51 Billion
  • Q2 2024

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 06, 2023
SELL
$98.98 - $115.74 $1.68 Million - $1.96 Million
-16,941 Reduced 29.33%
40,812 $4.72 Million
Q2 2023

Jun 20, 2024
SELL
$96.34 - $112.38 $10 Million - $11.7 Million
-103,911 Reduced 64.28%
57,753 $5.94 Million
Q2 2023

Aug 04, 2023
SELL
$96.34 - $112.38 $10 Million - $11.7 Million
-103,911 Reduced 64.28%
57,753 $5.94 Million
Q1 2023

Jun 20, 2024
SELL
$107.32 - $113.5 $181 Million - $191 Million
-1,684,822 Reduced 91.24%
161,664 $17.6 Million
Q1 2023

Apr 28, 2023
SELL
$107.32 - $113.5 $181 Million - $191 Million
-1,684,822 Reduced 91.24%
161,664 $17.6 Million
Q4 2022

Jun 20, 2024
BUY
$62.39 - $113.8 $115 Million - $210 Million
1,846,486 New
1,846,486 $210 Million
Q4 2022

Feb 09, 2023
SELL
$62.39 - $113.8 $4.33 Million - $7.9 Million
-69,431 Reduced 3.62%
1,846,486 $210 Million
Q3 2022

Nov 10, 2022
SELL
$58.92 - $84.67 $10.8 Million - $15.5 Million
-183,607 Reduced 8.75%
1,915,917 $119 Million
Q2 2022

Aug 05, 2022
BUY
$79.4 - $116.36 $857,361 - $1.26 Million
10,798 Added 0.52%
2,099,524 $171 Million
Q1 2022

May 04, 2022
BUY
$86.42 - $109.81 $22.3 Million - $28.4 Million
258,346 Added 14.11%
2,088,726 $221 Million
Q4 2021

Feb 08, 2022
SELL
$98.56 - $119.91 $4.19 Million - $5.09 Million
-42,486 Reduced 2.27%
1,830,380 $197 Million
Q3 2021

Nov 15, 2021
BUY
$91.91 - $110.37 $5.17 Million - $6.21 Million
56,265 Added 3.1%
1,872,866 $205 Million
Q2 2021

Aug 10, 2021
SELL
$86.24 - $95.92 $6.69 Million - $7.44 Million
-77,600 Reduced 4.1%
1,816,601 $170 Million
Q1 2021

May 06, 2021
BUY
$71.83 - $95.48 $9.67 Million - $12.9 Million
134,636 Added 7.65%
1,894,201 $174 Million
Q4 2020

Feb 10, 2021
SELL
$67.0 - $84.39 $19.1 Million - $24 Million
-284,978 Reduced 13.94%
1,759,565 $129 Million
Q3 2020

Oct 21, 2020
SELL
$55.23 - $79.93 $4.35 Million - $6.29 Million
-78,734 Reduced 3.71%
2,044,543 $159 Million
Q2 2020

Aug 10, 2020
SELL
$30.2 - $56.98 $4.42 Million - $8.33 Million
-146,241 Reduced 6.44%
2,123,277 $118 Million
Q1 2020

May 13, 2020
BUY
$24.87 - $38.56 $10.7 Million - $16.6 Million
429,800 Added 23.36%
2,269,518 $67.2 Million
Q4 2019

Feb 18, 2020
BUY
$25.43 - $36.67 $8.81 Million - $12.7 Million
346,321 Added 23.19%
1,839,718 $66.6 Million
Q3 2019

Nov 13, 2019
BUY
$23.0 - $27.97 $34.3 Million - $41.8 Million
1,493,397 New
1,493,397 $40.7 Million

Others Institutions Holding HZNP

# of Institutions
39
Shares Held
2.07M
Call Options Held
0
Put Options Held
20K
View Full List

About Horizon Therapeutics Public Ltd Co

HZNP Quotes by TradingView
  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Abrdn PLC Portfolio

Follow Abrdn PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abrdn PLC, based on Form 13F filings with the SEC.

News

Stay updated on Abrdn PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email